Functioning as an aminoglycoside bactericidal antibiotic composed of amino sugars combined with ligand structures, gentamicin sulfate serves as a sulfate derivative sharing an antimicrobial spectrum similar to kanamycin. This active substance is predominantly utilized to combat systemic or localized infections triggered by Gram-negative pathogens such as Escherichia coli,Shigella dysenteriae,Klebsiella pneumoniae,Proteus species, and Pseudomonas aeruginosa. Additionally, in ophthalmic formulations, it is applied to manage conditions including conjunctivitis and keratitis.

Administered via the oral route for managing intestinal infections or as part of preoperative bowel cleansing regimens prior to colorectal procedures, this agent can also be co-administered with metronidazole or clindamycin to effectively minimize the incidence of postoperative surgical site infections in colonic interventions.

Parameters
| Melting point | 218-237°C |
| alpha | D25 +102° |
| density | 1.000 g/cm3 |
| storage temp. | 2-8°C |
| solubility | H2O: 50 mg/mL As stock solution, store at −20°C. Stable at 37°C for 5 days. |
| form | powder |
| color | colorless to light yellow |
| Odor | odorless |
| PH | 4.0-5.5 (0.1g/mL in H2O) |
| optical activity | [α]20/D +110±8°, c = 1% in H2O |
| biological source | Micromonospora purpurea |
| Water Solubility | Soluble in water |
| Merck | 134403 |
| InChIKey | RDEIXVOBVLKYNT-HDZPSJEVSA-N |
| CAS DataBase Reference | 1405-41-0(CAS DataBase Reference) |
| EPA Substance Registry System | Gentamicin sulfate (1405-41-0) |
Safety Information
| Hazard Codes | Xn |
| Risk Statements | 42/43 |
| Safety Statements | 23-36/37-45-22-24/25 |
| WGK Germany | 2 |
| RTECS | LY2625000 |
| F | 3 |
| HS Code | 29419010 |
| Toxicity | LD50 in mice (mg base/kg): 430 i.p.; 485 s.c.; 75 i.v.; >9050 orally (Black) |
